ERA4Health Prevent-OO projects granted

Two projects, involving CARIM researchers, have been awarded within the ERA4Health programme Prevent-OO: Understanding and Preventing Overweight and Obesity.

In the project ‘Microvascular Impairment in Obesity: Biology, Evaluation, and Advanced Therapies (MICROBEAT)’, involving Dr Boy Houben (Dept of Internal Medicine), it is hypothesised that impairments in (endothelial) lipid handling and inflammation underlie microvascular dysfunction and, consequently, HFpEF in people with obesity. MICROBEAT will integrate sophisticated mechanistic experiments in cell and rodent models, acute human intervention studies and human cohort studies to identify causal pathways and therapeutic targets to improve microvascular dysfunction. The project is coordinated by Liz Jones (KU Leuven and Maastricht University) also involving Marie-Ange Renault (INSMER), Gijs Goossens (Maastricht University), and Ellen Buijnink (NVOO).

The project ‘Targeting xCT to mANAge obesity anD neUrological comorbidities (xANADU)’, involving Dr Kristiaan Wouters (Dept of Internal Medicine), together with Ann Massie (VUB Brussels) and Elise Dalmas (INSERM-IMMEDIAB, Paris), investigates if and how xCT, the specific subunit of the cystine/glutamate antiporter, links obesity and neurological decline in mice and humans, including whether combining xCT targeting inhibition with a GLP-1 receptor agonist offers added benefit. In Maastricht, we will validate the findings in the Maastricht Study cohort and use Mendelian Randomisation to assess whether xCT plays a causal role in humans. The long-term goal is a therapeutic strategy that improves metabolic and brain health together.

Overview